BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30015658)

  • 1. Prospective Serial FDG PET/CT During Treatment of Extrapulmonary Tuberculosis in HIV-Infected Patients: An Exploratory Study.
    Martin C; Castaigne C; Vierasu I; Garcia C; Wyndham-Thomas C; de Wit S
    Clin Nucl Med; 2018 Sep; 43(9):635-640. PubMed ID: 30015658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential
    Bomanji J; Sharma R; Mittal BR; Gambhir S; Qureshy A; Begum SMF; Paez D; Sathekge M; Vorster M; Sobic Saranovic D; Pusuwan P; Mann V; Vinjamuri S; Zumla A; Pascual TNB
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3118-3129. PubMed ID: 32483653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of
    Lefebvre N; Argemi X; Meyer N; Mootien J; Douiri N; Sferrazza-Mandala S; Schramm F; Weingertner N; Christmann D; Hansmann Y; Imperiale A
    Nucl Med Biol; 2017 Jul; 50():17-24. PubMed ID: 28426991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET imaging in HIV infection and tuberculosis.
    Sathekge M; Maes A; Van de Wiele C
    Semin Nucl Med; 2013 Sep; 43(5):349-66. PubMed ID: 23905617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards more accurate
    Priftakis D; Riaz S; Zumla A; Bomanji J
    Int J Infect Dis; 2020 Mar; 92S():S85-S90. PubMed ID: 32114199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT in Tuberculosis: Can Interim PET/CT Predict the Clinical Outcome of the Patients?
    Sood A; Mittal BR; Modi M; Chhabra R; Verma R; Rana N; Parihar AS; Satapathy S; Kumar R
    Clin Nucl Med; 2020 Apr; 45(4):276-282. PubMed ID: 32108701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response.
    Martinez V; Castilla-Lievre MA; Guillet-Caruba C; Grenier G; Fior R; Desarnaud S; Doucet-Populaire F; Boué F
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1180-5. PubMed ID: 22794271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis.
    Sathekge M; Maes A; Kgomo M; Stoltz A; Van de Wiele C
    J Nucl Med; 2011 Jun; 52(6):880-5. PubMed ID: 21571788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG uptake in lymph-nodes of HIV+ and tuberculosis patients: implications for cancer staging.
    Sathekge M; Maes A; Kgomo M; Pottel H; Stolz A; Van De Wiele C
    Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):698-703. PubMed ID: 21150859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Gongxeka H; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1184-90. PubMed ID: 22526957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT.
    Vorster M; Sathekge MM; Bomanji J
    Curr Opin Pulm Med; 2014 May; 20(3):287-93. PubMed ID: 24614238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic Lymph Node Staging by Combined
    Pichler R; De Zordo T; Fritz J; Kroiss A; Aigner F; Heidegger I; Virgolini I; Horninger W; Uprimny C
    Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing gene expression profiles of adults with isolated spinal tuberculosis to disseminated spinal tuberculosis identified by
    Scherer J; Mukasa SL; Wolmarans K; Guler R; Kotze T; Song T; Dunn R; Laubscher M; Pape HC; Held M; Thienemann F
    J Orthop Surg Res; 2024 Jun; 19(1):376. PubMed ID: 38918806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis.
    Tian G; Xiao Y; Chen B; Xia J; Guan H; Deng Q
    Acta Radiol; 2010 Nov; 51(9):1002-6. PubMed ID: 20942732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis.
    Ankrah AO; Glaudemans AWJM; Maes A; Van de Wiele C; Dierckx RAJO; Vorster M; Sathekge MM
    Semin Nucl Med; 2018 Mar; 48(2):108-130. PubMed ID: 29452616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark.
    Jakobsen JK; Alslev L; Ipsen P; Costa JC; Krarup KP; Sommer P; Nerstrøm H; Toft BG; Høyer S; Bouchelouche K; Jensen JB
    BJU Int; 2016 Jul; 118(1):102-11. PubMed ID: 26216234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Fluorine(18)-fluorodeoxyglucose and Gallium(68)-citrate PET/CT in patients with tuberculosis.
    Ankrah AO; Lawal IO; Boshomane TMG; Klein HC; Ebenhan T; Dierckx RAJO; Vorster M; Glaudemans AWJM; Sathekge MM
    Nuklearmedizin; 2019 Sep; 58(5):371-378. PubMed ID: 31486054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of extrapulmonary tuberculosis in (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography: experience from 39 cases].
    Liu GC; Gao S; Cai L; Chen QS
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Mar; 35(3):184-8. PubMed ID: 22781150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With Tuberculosis.
    Stelzmueller I; Huber H; Wunn R; Hodolic M; Mandl M; Lamprecht B; Schinko H; Fellner F; Skanjeti A; Giammarile F; Colletti PM; Rubello D; Gabriel M
    Clin Nucl Med; 2016 Apr; 41(4):e187-94. PubMed ID: 26704732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.